Exenatide does not affect mitochondrial COX activity in 3xTg-AD mice [44], while Liraglutide improves mitochondrial function by reducing 8-OHdG, nitrite, carbonyl groups and TBARS levels, and decreases Fis1 and Opa overexpression in the same model [51]. This evidence concerns the gene FIS1 and Alzheimer disease.